Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of KIF5b-mediated Nav1.8 transport by ropivacaine contributes to axonal regeneration following sciatic nerve injury in rats. | Neuropharmacology | 2024 | 39332671 | PubTator, text mining | PubMed |
| Diagnosis, Treatment Patterns, and Outcomes in Real-World Patients with RET Fusion-Positive Non-small Cell Lung Cancer in China. | Adv Ther | 2024 | 39316291 | PubTator, text mining | PubMed |
| Systems mapping of bidirectional endosomal transport through the crowded cell. | Curr Biol | 2024 | 39276769 | PubTator, text mining | PubMed |
| MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer. | Cancer Lett | 2024 | 39244004 | PubTator, text mining | PubMed |
| Small cell lung carcinoma with KIF5B-RET fusion partially responded to the 4th-line therapy with anlotinib: A case report. | World J Clin Cases | 2024 | 39156099 | PubTator, text mining | PubMed |
| The endolysosomal system in conventional and unconventional protein secretion. | J Cell Biol | 2024 | 39133205 | PubTator, text mining | PubMed |
| Molecular analysis of non-small cell lung cancer using a dual-targeted DNA and RNA comprehensive genomic profiling panel. | Respir Investig | 2024 | 39126824 | PubTator, text mining | PubMed |
| Static magnetic field-modulated mesenchymal stem cell-derived mitochondria-containing microvesicles for enhanced intervertebral disc degeneration therapy. | J Nanobiotechnology | 2024 | 39085827 | PubTator, text mining | PubMed |
| Kinesin-1-transported liposomes prefer to go straight in 3D microtubule intersections by a mechanism shared by other molecular motors. | Proc Natl Acad Sci U S A | 2024 | 38980901 | PubTator, text mining | PubMed |
| Low-intensity pulsed ultrasound improves myocardial ischaemia‒reperfusion injury via migrasome-mediated mitocytosis. | Clin Transl Med | 2024 | 38951127 | PubTator, text mining | PubMed |
| Beyond fission and fusion-Diving into the mysteries of mitochondrial shape. | PLoS Biol | 2024 | 38949997 | PubTator, text mining | PubMed |
| LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis. | Oncol Res | 2024 | 38948025 | PubTator, text mining | PubMed |
| A dual role of ERGIC-localized Rabs in TMED10-mediated unconventional protein secretion. | Nat Cell Biol | 2024 | 38926505 | PubTator, text mining | PubMed |
| The heterotrimeric kinesin-2 family member KIF3A directly binds to disabled-1 (Dab1). | BMB Rep | 2024 | 38919020 | PubTator, text mining | PubMed |
| A Platform for Medium-Throughput Cell-Free Analyses of Microtubule-Interacting Proteins Using Mammalian Cell Lysates. | Curr Protoc | 2024 | 38865215 | PubTator, text mining | PubMed |
| ALK-Rearranged Renal Cell Carcinoma: A Multi-Institutional Study of 9 Cases With Expanding the Morphologic and Molecular Genetic Spectrum. | Mod Pathol | 2024 | 38852815 | PubTator, text mining | PubMed |
LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET+) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC. | Lung Cancer (Auckl) | 2024 | 38807655 | PubTator, text mining | PubMed |
| Case report: Systemic presentation of ALK-positive Histiocytosis. | Front Oncol | 2024 | 38706599 | PubTator, text mining | PubMed |
| Case report: Acquired resistance to crizotinib from a MET Y1230H mutation in a patient with non-small cell lung cancer and KIF5B-MET fusion. | Front Oncol | 2024 | 38690167 | PubTator, text mining | PubMed |
| DNA double-strand break-capturing nuclear envelope tubules drive DNA repair. | Nat Struct Mol Biol | 2024 | 38632359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=6